Eating frequency predicts new onset hypertension and the rate of progression of blood pressure, arterial stiffness, and wave reflections

Journal of Hypertension
Kalliopi KaratziKimon S Stamatelopoulos

Abstract

Cross-sectional evidence indicates that eating frequency correlates with blood pressure, hypertension, and related target organ damage. The aim of the present study was to prospectively assess eating frequency as a predictor of arteriosclerosis progression and new onset hypertension over a follow-up period of 5 years in adults without cardiovascular disease. Eating frequency among other dietary parameters was evaluated in 115 nondiabetic study participants from a general population sample (54 ± 9.1 years, 45 women) at a baseline visit. Metabolic parameters known to be associated with eating frequency, markers of arteriosclerosis, including augmentation index, pulse wave velocity, SBP, and DBP were evaluated in all volunteers at baseline and after a 5-year follow-up. By applying linear mixed models analysis, it was found that a high eating frequency at baseline significantly correlated with the rate of progression of pulse wave velocity (β = 0.521, P = 0.004), augmentation index (β = 0.503, P = 0.01), SBP (β = 0.694, P < 0.001), and DBP (β = 0.477, P = 0.009) and the incidence of new onset hypertension (odds ratio = 8.89, P < 0.001). After adjustment traditional cardiovascular risk factors, heart rate, homeostasis model assessme...Continue Reading

References

Oct 5, 1989·The New England Journal of Medicine·D J JenkinsW Singer
May 1, 1966·The American Journal of Clinical Nutrition·P FábryJ Pechar
Apr 1, 1995·Metabolism: Clinical and Experimental·D J JenkinsS C Cunnane
Mar 1, 1993·The American Journal of Clinical Nutrition·L M ArnoldJ Mann
Mar 21, 1998·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·S E DrummondT R Kirk
Jan 16, 2002·Current Opinion in Lipidology·Frank B Hu
Aug 13, 2002·Current Opinion in Clinical Nutrition and Metabolic Care·Klaas R Westerterp, Annelies H C Goris
Jan 18, 2007·Obesity·Mary YannakouliaNikos Yiannakouris
Apr 7, 2007·The American Journal of Clinical Nutrition·Kim S StoteMark P Mattson
Jun 15, 2007·International Journal of Obesity : Journal of the International Association for the Study of Obesity·D L FrankoP B Crawford
Apr 5, 2008·Obesity·Justo Sierra-JohnsonMai-Lis Hellénius
Apr 15, 2009·Circulation·Mark A HlatkyUNKNOWN American Heart Association Expert Panel on Subclinical Atherosclerotic Diseases and Emerging Risk Factors and the Stroke Cou
May 20, 2009·Hypertension·George A GeorgiopoulosChristos Papamichael
Jun 19, 2009·The American Journal of Clinical Nutrition·Kiran D K AhujaMadeleine J Ball
Jun 10, 2010·European Heart Journal·UNKNOWN Reference Values for Arterial Stiffness' Collaboration
Jan 6, 2012·The American Journal of Clinical Nutrition·Lorrene D Ritchie
Sep 6, 2012·JAMA : the Journal of the American Medical Association·Bernhard M KaessGary F Mitchell
Apr 10, 2013·Pediatrics·Panagiota KaisariDemosthenes B Panagiotakos
Mar 25, 2014·The British Journal of Nutrition·Kentaro Murakami, M Barbara E Livingstone
May 23, 2014·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Kalliopi KaratziKimon Stamatelopoulos

❮ Previous
Next ❯

Citations

Aug 29, 2020·Journal of the American Heart Association·Jack Wilson, Alastair John Stewart Webb
Oct 11, 2017·QJM : Monthly Journal of the Association of Physicians·G GeorgiopoulosK Stamatelopoulos
Jun 8, 2018·European Journal of Nutrition·Rebecca M LeechSarah A McNaughton

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA

Software Mentioned

STATA
GPower
psmatch2
Nutritionist Pro
Axxya

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Related Papers

Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
R A MangiaficoC E Fiore
American Journal of Hypertension
Prithvi Shiva KumarPREVENCION Investigators
© 2022 Meta ULC. All rights reserved